Pathstone Family Office, LLC Myriad Genetics Inc Call Options Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$226 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$158 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$89.5 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$82.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$64.7 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.2B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...